Literature DB >> 31363834

Arthroscopic autologous chondrocyte implantation in the knee with an in situ crosslinking matrix: minimum 4-year clinical results of 15 cases and 1 histological evaluation.

Michael Schlumberger1, Philipp Schuster2,3, Hans-Jörg Bülow2, Philipp Mayer2, Martin Eichinger2,4, Jörg Richter2.   

Abstract

PURPOSE: To clinically evaluate an arthroscopic autologous chondrocyte implantation (ACI) technique with an in situ crosslinking matrix for the treatment of full thickness cartilage defects of the knee and to present histological results of a graft cartilage biopsy obtained after 1.5 years.
METHODS: Fifteen cases of arthroscopic autologous chondrocyte implantation in the knee performed between November 2011 and October 2012 were included in the study. Medical charts and operational reports were screened and the patients were contacted after 0.8 ± 0.3 years (0.4-1.3) and 4.3 ± 0.3 years (4.0-4.8) to asses subjective IKDC and re-operation. The Tegner activity scale was collected at the second follow-up time point. Subjective IKDC response rates were assessed at both follow-up time points.
RESULTS: The first and second follow-up was completed by all 15 patients (100%). The subjective IKDC scores showed a significant improvement (pre-operative 44.5 ± 15.9, first follow-up 71.1 ± 15.9, p < 0.001, second follow-up 72.6 ± 17.3, p < 0.001). The overall response rate was 66.7% (n = 10) at follow-up one and two. There were no significant differences in pre-injury (4, range 1-9) and follow-up two (4, range 2-7) Tegner activity scales (p = n.s.). Two patients required re-operation in the index knee, not related to the ACI procedure. No complication related to the ACI or the implantation technique occurred. The histological results showed excellent cartilage regeneration.
CONCLUSION: Arthroscopic ACI using an in situ crosslinking matrix is a safe and reliable treatment option for full-thickness cartilage defects of the knee.

Entities:  

Keywords:  ACI; Arthroscopic; Autologous chondrocyte implantation; Cartilage defect; Cartilage repair; Histological results; Inject; Knee; Two-stage cartilage repair

Year:  2019        PMID: 31363834     DOI: 10.1007/s00402-019-03243-2

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  2 in total

1.  Treatment of Large Cartilage Defects in the Knee by Hydrogel-Based Autologous Chondrocyte Implantation: Two-Year Results of a Prospective, Multicenter, Single-Arm Phase III Trial.

Authors:  P Niemeyer; M Hanus; J Belickas; T László; R Gudas; M Fiodorovas; A Cebatorius; M Pastucha; P Hoza; K Magos; K Izadpanah; L Paša; G Vásárhelyi; K Sisák; M Mohyla; C Farkas; O Kessler; S Kybal; R Spiro; A Köhler; A Kirner; S Trattnig; C Gaissmaier
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

2.  Hydrogel-based autologous chondrocyte implantation leads to subjective improvement levels comparable to scaffold based autologous chondrocyte implantation.

Authors:  Thomas Richard Niethammer; Felix Uhlemann; Anja Zhang; Martin Holzgruber; Ferdinand Wagner; Peter Ernst Müller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-02-28       Impact factor: 4.114

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.